Dr Carlyle received a BA (Hons) in Medical Sciences from Oxford University in 2005. She completed her PhD at the University of Edinburgh, working on Disrupted in Schizophrenia 1 and cAMP signalling in the group of Kirsty Millar & David Porteous in 2010. After moving to Yale to work for Dr Arthur Simen in 2010, where she worked on mouse models of childhood neglect and aging, Dr Carlyle transferred to the lab of Professor Angus Nairn in 2012. Since joining the lab she has worked on a series of projects related to measurement of the translatome and proteome in specific neural cell types. Her projects cover multiple research fields including cocaine abuse, Alzheimer's Disease, and Major Depressive Disorder. In 2014 she was awarded a NARSAD Young Investigator Award for studying protein translation and the rapid antidepressant effects of Ketamine, and was promoted to Associate Research Scientist in 2016.
Friday, October 6, 2017 at 4:00pm to 5:00pm
Icahn School of Medicine at Mount Sinai, Hess Seminar Room B
One Gustave L. Levy Place New York, NY 10029-6574